NCCM
AGTC

Nine Chapters Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Nine Chapters Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$113K Buy
+28,500
New +$131K 0.25% 119
2017
Q2 		– Sell
-63,700
Closed -$440K – 204
2017
Q1 		$440K Buy
+63,700
New +$498K 0.59% 53

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nine Chapters Capital Management's AGTC Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in Applied Genetic Technologies Corporation (AGTC) in Q3 2017: 28,500 shares worth $113K. The stake represents 0.25% of the portfolio and ranks #119 among its holdings. This is a return to the name: Nine Chapters Capital Management previously reported a position in AGTC as recently as Q1 2017.

Nine Chapters Capital Management first reported a position in AGTC in Q1 2017 and has held it in 2 quarters since. The position peaked at $440K in Q1 2017. 67 funds tracked by Wall St. Rank hold AGTC as of Q3 2017.

  • Nine Chapters Capital Management held 28,500 shares of Applied Genetic Technologies Corporation worth $113K as of Q3 2017.
  • Applied Genetic Technologies Corporation was a new Nine Chapters Capital Management position in Q3 2017.
  • Applied Genetic Technologies Corporation made up 0.25% of Nine Chapters Capital Management's portfolio in Q3 2017, its #119 holding.
  • Nine Chapters Capital Management first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and has held it in 2 quarters since.
  • Nine Chapters Capital Management's Applied Genetic Technologies Corporation position peaked at $440K in Q1 2017.
  • 67 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.